We are live on ! Find out more
SI

Scharf Investments Portfolio holdings

AUM $3.03B
1-Year Est. Return 7.75%
This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+7.75%
3 Year Est. Return
+55.03%
5 Year Est. Return
+80.17%
10 Year Est. Return
+289.59%
AUM
$3.72B
AUM Growth
-$255M
Cap. Flow
-$156M
Cap. Flow %
-4.19%
Top 10 Hldgs %
45.67%
Holding
78
New
9
Increased
14
Reduced
43
Closed
6

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$99.7M
2
MRSH
Marsh
MRSH
+$66.9M
3
BKNG icon
Booking.com
BKNG
+$57.4M
4
UNH icon
UnitedHealth
UNH
+$48.5M
5
ZTS icon
Zoetis
ZTS
+$42.3M

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$93.5M
2
CMCSA icon
Comcast
CMCSA
+$68.2M
3
MCK icon
McKesson
MCK
+$48.1M
4
DCI icon
Donaldson
DCI
+$43.3M
5
NVS icon
Novartis
NVS
+$32.5M

Sector Composition

Rank Sector Weight
1 Financials 25.67%
2 Healthcare 22.42%
3 Industrials 11.46%
4 Technology 10.27%
5 Communication Services 5.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GGAL icon
76
Galicia Financial Group
GGAL
$7.42B
-27,686
Closed -$763K
KRC icon
77
Kilroy Realty
KRC
$4.42B
-4,963
Closed -$210K
SONY icon
78
Sony
SONY
$138B
-181,601
Closed -$5.23M

Similar funds

Scharf Investments's Q4 2025 Portfolio in Review

As of Q4 2025, Scharf Investments held 78 positions worth $3.72B, down 6.4% from $3.98B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Scharf Investments withdrew a net $156M in Q4 2025, closing 6 positions and reducing 43 holdings. Its most notable exit was AstraZeneca, an estimated $7.09M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Scharf Investments opened a new position in Marsh worth $66.4M.

  • Scharf Investments's largest Q4 2025 buy was Marsh: 357,764 shares worth $66.4M.
  • Scharf Investments added most to Meta Platforms (Facebook) in Q4 2025, an estimated $99.7M increase.
  • Scharf Investments's biggest Q4 2025 reduction was Fiserv Inc, cutting an estimated $93.5M.
  • Scharf Investments fully exited AstraZeneca in Q4 2025, selling an estimated $7.09M.
  • Scharf Investments's ten largest holdings make up 46% of its $3.72B portfolio in Q4 2025.
  • Scharf Investments opened 9 new positions and closed 6 in Q4 2025.
  • Scharf Investments's portfolio value fell 6.4% quarter-over-quarter to $3.72B.

Based on Scharf Investments's 13F filing for Q4 2025, filed 15 Jan 2026.